Top

Published in:

01-11-2011 | Original Article

Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging

Authors: Rosalinda T. Castaneda, Sophie Boddington, Tobias D. Henning, Mike Wendland, Lydia Mandrussow, Siyuan Liu, Heike Daldrup-Link

Published in: Pediatric Radiology | Issue 11/2011

Abstract

Background

Human embryonic stem cells (hESC) can generate cardiomyocytes (CM), which offer promising treatments for cardiomyopathies in children. However, challenges for clinical translation result from loss of transplanted cell from target sites and high cell death. An imaging technique that noninvasively and repetitively monitors transplanted hESC-CM could guide improvements in transplantation techniques and advance therapies.

Objective

To develop a clinically applicable labeling technique for hESC-CM with FDA-approved superparamagnetic iron oxide nanoparticles (SPIO) by examining labeling before and after CM differentiation.

Materials and methods

Triplicates of hESC were labeled by simple incubation with 50 μg/ml of ferumoxides before or after differentiation into CM, then imaged on a 7T MR scanner using a T2-weighted multi-echo spin-echo sequence. Viability, iron uptake and T2-relaxation times were compared between groups using t-tests.

Results

hESC-CM labeled before differentiation demonstrated significant MR effects, iron uptake and preserved function. hESC-CM labeled after differentiation showed no significant iron uptake or change in MR signal (P < 0.05). Morphology, differentiation and viability were consistent between experimental groups.

Conclusion

hESC-CM should be labeled prior to CM differentiation to achieve a significant MR signal. This technique permits monitoring delivery and engraftment of hESC-CM for potential advancements of stem cell-based therapies in the reconstitution of damaged myocardium.

Available only for authorised users

Lipshultz SE, Sleeper LA, Towbin JA et al (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647–1655PubMedCrossRef

Rosamond W, Flegal K, Friday G et al (2007) Heart disease and stroke statistics—2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 115:e-69–e-171CrossRef

Bettiol E, Clement S, Krause KH et al (2006) Embryonic and adult stem cell-derived cardiomyocytes: lessons from in vitro models. Rev Physiol Biochem Pharmacol 157:1–30PubMed

Laflamme MA, Chen KY, Naumova AV et al (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infracted rat hearts. Nat Biotechnol 25:1015–1024PubMedCrossRef

Yamada S, Nelson TJ, Crespo-Diaz RJ et al (2008) Embryonic stem cell therapy of heart failure in genetic cardiomyopathy. Stem Cells 26:2644–2653PubMedCrossRef

van Laake LW, Passier R, Doevendans PA et al (2008) Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res 102:1008–1010PubMedCrossRef

Oyamada N, Itoh H, Sone M et al (2008) Transplantation of vascular cells derived from human embryonic stem cells contributes to vascular regeneration after stroke in mice. J Transl Med 6:54PubMedCrossRef

Au KW, Liao SY, Lee YK et al (2009) Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells. Biochem Biophys Res Commun 379:898–903PubMedCrossRef

Fraidenraich D, Benezra R (2006) Embryonic stem cells prevent developmental cardiac defects in mice. Nat Clin Pract Cardiovasc Med 3(Suppl 1):S14–S17PubMedCrossRef

10.

Martens TP, Godier AF, Parks JJ et al (2009) Percutaneous cell delivery into the heart using hydrogels polymerizing in situ. Cell Transplant 18:297–304PubMedCrossRef

11.

Cao F, Wagner RA, Wilson KD et al (2008) Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS ONE 3:e3474PubMedCrossRef

12.

Li SH, Lai TY, Sun Z et al (2009) Tracking cardiac engraftment and distribution of implanted bone marrow cells: comparing intra-aortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg 137(1225–1233):e1221

13.

Cao F, Lin S, Xie X et al (2006) In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation 113:1005–1014PubMedCrossRef

14.

Semont A, Francois S, Mouiseddine M et al (2006) Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol 585:19–30PubMedCrossRef

15.

Lau JF, Anderson SA, Adler E et al (2010) Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol 7:97–105PubMedCrossRef

16.

Ye Y, Bogaert J (2008) Cell therapy in myocardial infarction: emphasis on the role of MRI. Eur Radiol 18:548–569PubMedCrossRef

17.

Nedopil A, Klenk C, Kim C et al (2010) MR signal characteristics of viable and apoptotic human mesenchymal stem cells in matrix-associated stem cell implants for treatment of osteoarthritis. Invest Radiol 45:634–640PubMedCrossRef

18.

Bratt-Leal AM, Carpenedo RL, McDevitt TC (2009) Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog 25:43–51PubMedCrossRef

19.

Maltsev VA, Wobus AM, Rohwedel J et al (1994) Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes to ionic currents. Circ Res 75:233–244PubMed

20.

Sykova E, Jendelova P (2007) Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ 14:1336–1342PubMedCrossRef

21.

Wang YX, Hussain SM, Krestin GP (2001) Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 11:2319–2331PubMedCrossRef

22.

Jung CW, Jacobs P (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13:661–674PubMedCrossRef

23.

Metz S, Bonaterra G, Rudelius M et al (2004) Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 14:1851–1858PubMedCrossRef

24.

Bulte JW, Ma LD, Magin RL et al (1993) Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles. Magn Reson Med 29:32–37PubMedCrossRef

25.

Schulze E, Ferrucci JT Jr, Poss K et al (1995) Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest Radiol 30:604–610PubMedCrossRef

26.

Bulte JW (2009) In vivo MRI cell tracking: clinical studies. AJR 193:314–325PubMedCrossRef

27.

Arbab AS, Yocum GT, Kalish H et al (2004) Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217–1223PubMedCrossRef

28.

Kim HS, Oh SY, Joo HJ et al (2010) The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells. NMR Biomed 23:514–522PubMedCrossRef

29.

Chung J, Yamada M, Yang PC (2009) Magnetic resonance imaging of human embryonic stem cells. Curr Protoc Stem Cell Biol Chapter 5:Unit 5A 3

30.

Adler ED, Bystrup A, Briley-Saebo KC et al (2009) In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium. JACC Cardiovasc Imaging 2:1114–1122PubMedCrossRef

31.

Josephson L, Tung CH, Moore A et al (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186–191PubMedCrossRef

32.

Wang L, Wang Z, Frank TG et al (2009) Rapid and efficient cell labeling with a MRI contrast agent by electroporation in the presence of protamine sulfate. Nanomedicine (Lond) 4:305–315CrossRef

33.

Bulte JW, Kraitchman DL, Mackay AM et al (2004) Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 104:3410–3412, author reply 3412–3413PubMedCrossRef

34.

Nohroudi K, Arnhold S, Berhorn T et al (2010) In vivo MRI stem cell tracking requires balancing of detection limit and cell viability. Cell Transplant 19:431–441PubMedCrossRef

35.

Lee JK, Lee MK, Jin HJ et al (2007) Efficient intracytoplasmic labeling of human umbilical cord blood mesenchymal stromal cells with ferumoxides. Cell Transplant 16:849–857PubMed

36.

Henning TD, Sutton EJ, Kim A et al (2009) The influence of ferucarbotran on the chondrogenesis of human mesenchymal stem cells. Contrast Media Mol Imaging 4:165–173PubMedCrossRef

37.

Henning TD, Boddington S, Daldrup-Link HE (2008) Labeling hESCs and hMSCs with iron oxide nanoparticles for non-invasive in vivo tracking with MR imaging. J Vis Exp 31:pii 685

38.

Maxwell DJ, Bonde J, Hess DA et al (2008) Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells 26:517–524PubMedCrossRef

39.

Thu MS, Najbauer J, Kendall SE et al (2009) Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS ONE 4:e7218PubMedCrossRef

40.

Tallheden T, Nannmark U, Lorentzon M et al (2006) In vivo MR imaging of magnetically labeled human embryonic stem cells. Life Sci 79:999–1006PubMedCrossRef

41.

Huang ZY, Ge JB, Yang S et al (2007) In vivo cardiac magnetic resonance imaging of superparamagnetic iron oxides-labeled mesenchymal stem cells in swines. Zhonghua Xin Xue Guan Bing Za Zhi 35:344–349PubMed

42.

Hung TC, Suzuki Y, Urashima T et al (2008) Multimodality evaluation of the viability of stem cells delivered into different zones of myocardial infarction. Circ Cardiovasc Imaging 1:6–13PubMedCrossRef

43.

Anisimov SV, Morizane A, Correia AS (2010) Risks and mechanisms of oncological disease following stem cell transplantation. Stem Cell Rev 6:411–424PubMedCrossRef

44.

Hentze H, Soong PL, Wang ST et al (2009) Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res 2:198–210PubMedCrossRef

45.

Stuckey DJ, Carr CA, Martin-Rendon E et al (2006) Iron particles for noninvasive monitoring of bone marrow stromal cell engraftment into, and isolation of viable engrafted donor cells from, the heart. Stem Cells 24:1968–1975PubMedCrossRef

46.

Kraitchman DL, Heldman AW, Atalar E et al (2003) In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107:2290–2293PubMedCrossRef

47.

Li Z, Suzuki Y, Huang M et al (2008) Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 26:864–873PubMedCrossRef

48.

Crabbe A, Vandeputte C, Dresselaers T et al (2010) Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant 19:919–936PubMedCrossRef

49.

Jendelova P, Herynek V, Urdzikova L et al (2004) Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 76:232–243PubMedCrossRef

50.

Mani V, Adler E, Briley-Saebo KC et al (2008) Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med 60:73–81PubMedCrossRef

51.

Wang B, Jaconi M, Li J et al (2007) MR imaging of embryonic stem cells labeled by superparamagnetic iron oxide. Zhonghua Yi Xue Za Zhi 87:1646–1648PubMed

52.

Kalish H, Arbab AS, Miller BR et al (2003) Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn Reson Med 50:275–282PubMedCrossRef

53.

Charriere GM, Cousin B, Arnaud E et al (2006) Macrophage characteristics of stem cells revealed by transcriptome profiling. Exp Cell Res 312:3205–3214PubMedCrossRef

54.

Terrovitis J, Stuber M, Youssef A et al (2008) Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 117:1555–1562PubMedCrossRef

55.

Amsalem Y, Mardor Y, Feinberg MS et al (2007) Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infracted myocardium. Circulation 116:I38–I45PubMedCrossRef

56.

Pawelczyk E, Jordan EK, Balakumaran A et al (2009) In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS ONE 4:e6712PubMedCrossRef

57.

Berman SC, Galpoththawela C, Gilad AA et al (2011) Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn Reson Med 65:564–574PubMedCrossRef

58.

Yamada T, Yoshikawa M, Kanda S et al (2002) In vitro differentiation of embryonic stem cells into hepatocyte-like cells identified by cellular uptake of indocyanine green. Stem Cells 20:146–154PubMedCrossRef

59.

Lei Y, Tang H, Feng M et al (2009) Applications of fluorescent quantum dots to stem cell tracing in vivo. J Nanosci Nanotechnol 9:5726–5730PubMedCrossRef

60.

Boddington SE, Henning TD, Jha P et al (2010) Labeling human embryonic stem cell-derived cardiomyocytes with indocyanine green for noninvasive tracking with optical imaging: an FDA-compatible alternative to firefly luciferase. Cell Transplant 19:55–65PubMedCrossRef

61.

Terrovitis J, Lautamaki R, Bonios M et al (2009) Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 54:1619–1626PubMedCrossRef

62.

Qiao H, Zhang H, Zheng Y et al (2009) Embryonic stem cell grafting in normal and infracted myocardium: serial assessment with MR imaging and PET dual detection. Radiology 250:821–829PubMedCrossRef

63.

Zhang Y, Ruel M, Beanlands RS et al (2008) Tracking stem cell therapy in the myocardium: applications of positron emission tomography. Curr Pharm Des 14:3835–3853PubMedCrossRef

64.

Thomson JA, Itskovitz-Eldor J, Shapiro SS et al (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145–1147PubMedCrossRef

Title: Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging
Authors: Rosalinda T. Castaneda
Sophie Boddington
Tobias D. Henning
Mike Wendland
Lydia Mandrussow
Siyuan Liu
Heike Daldrup-Link
Publication date: 01-11-2011
Publisher: Springer-Verlag
Published in: Pediatric Radiology / Issue 11/2011
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI: https://doi.org/10.1007/s00247-011-2130-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Labeling human embryonic stem-cell-derived cardiomyocytes for tracking with MR imaging

Abstract

Background

Objective

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Objective

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2011

Normal conus medullaris FDG uptake in children

ELECTRICA: ELEctronic knowledge base for Clinical care, Teaching and Research In Child Abuse

Contrast-enhanced US (CEUS) in children: ready for prime time in the United States

A rare case of thymoma in a 15-month-old girl

Medication neurotoxicity in children

Interloop fluid in intussusception